| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |